ATBECHDEDKESFRGBGRITLILUNLSEMCPTIESILTLVFIROMKCYALTRBGCZEEHUPLSK..HRIS..MTNORS..SM..................*JBDM Ver 1.7.2 (20 November 2019) - 2999001/03200812CORRECTED EUROPEAN PATENT SPECIFICATIONB8B120210428W173deBibliographieenBibliographyfrBibliographieEP15846131.9201510012017050120181210enenen201462058506 P20141001US201462058510 P20141001US201562149257 P20150417US201562192934 P20150715US2021042820211720170809201732202011252020482020041720210428202117A61K 38/10 20060101AFI20180119BHEP deNEUARTIGE ALPHA4BETA7-PEPTIDMONOMER- UND -DIMERANTAGONISTENenNOVEL ALPHA4BETA7 PEPTIDE MONOMER AND DIMER ANTAGONISTSfrNOUVEAUX ANTAGONISTES PEPTIDIQUES MONOMÈRES ET DIMÈRES DE ALPHA4BETA7WO-A1-2014/059213WO-A1-2016/054445US-A1- 2006 183 884US-A1- 2009 257 952GEE ET AL.: 'Cyclic Peptides as Non-carboxyl-terminal Ligands of Syntrophin PDZ Domains' THE JOURNAL OF BIOLOGICAL CHEMISTRY vol. 273, no. 34, 21 August 1998, pages 21980 - 21987, XP002155720 DOI: 10.1074/JBC.273.34.21980LIU, S.: 'Radiolabeled Cyclic RGD Peptides as Integrin alphavbeta3-Targeted Radiotracers: Maximizing Binding Affinity via Bivalency' BIOCONJ CHEM. vol. 20, no. 12, 01 December 2010, pages 2199 - 2213, XP055424110 DOI: 10.1021/BC900167C2018012520209378.720201124BHANDARI, Ashok2629 Lotus StreetPleasanton, California 94588USPATEL, Dinesh V.45109 Cougar CircleFremont, California 94539USZEMEDE, Genet1417 Glacier DriveSan Jose, California 95118USMATTHEAKIS, Larry C.20612 Sunrise DriveCupertino, California 95014USLIU, Davidc/o Protagonist Therapeutics Inc. 521 Cottonwood Drive Suite AMilpitas, California 95035USProtagonist Therapeutics, Inc.101892573COL15996PCTEP7707 Gateway Boulevard, Suite 140Newark, CA 94560-1160USSchiweck Weinzierl Koch Patentanwälte Partnerschaft mbB101223256Ganghoferstraße 68 B80339 MünchenDEALATBEBGCHCYCZDEDKEEESFIFRGBGRHRHUIEISITLILTLULVMCMKMTNLNOPLPTRORSSESISKSMTRUS201505355820151001enWO201605441120160407201614